* Inspire Medical Systems Inc INSP.N reported a quarterly
adjusted loss of 34 cents per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -53 cents. The mean expectation of
eighteen analysts for the quarter was for a loss of 65 cents per
share. Wall Street expected results to range from -85 cents
to -41 cents per share.
* Revenue rose 28.2% to $164.01 million from a year ago;
analysts
expected $161.44 million.
* Inspire Medical Systems Inc's reported EPS for the quarter
was a
loss of 34 cents.
* The company reported a quarterly loss of $10.01 million.
* Inspire Medical Systems Inc shares had risen by 16.8% this
quarter and gained 23.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Inspire Medical
Systems Inc is $265.00
This summary was machine generated from LSEG data May 7 at 09:22
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.65 -0.34 Beat
Dec. 31 2023 -0.09 0.49 Beat
Sep. 30 2023 -0.58 -0.29 Beat
Jun. 30 2023 -0.57 -0.41 Beat